Lam Research financials
$323.86+2.99%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q4 '26 Jun 28 | Q3 '26 Mar 29 | Q2 '26 Dec 28 | Q1 '26 Sep 28 | Q4 '25 Jun 29 | Q3 '25 Mar 30 | Q2 '25 Dec 29 | Q1 '25 Sep 29 | Q4 '24 Jun 30 | Q3 '24 Mar 31 | Q2 '24 Dec 24 | Q1 '24 Sep 24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.72B | $5.84B | $5.34B | $5.32B | $5.17B | $4.72B | $4.38B | $4.17B | $3.87B | $3.79B | $3.76B | $3.48B |
| Gross profit | $3.48B | $2.91B | $2.65B | $2.68B | $2.59B | $2.31B | $2.07B | $2.00B | $1.84B | $1.80B | $1.76B | $1.66B |
| Gross margin | 51.7% | 49.8% | 49.6% | 50.4% | 50.1% | 49.0% | 47.4% | 48.0% | 47.5% | 47.5% | 46.8% | 47.7% |
| Operating income | $2.51B | $2.05B | $1.81B | $1.83B | $1.74B | $1.56B | $1.33B | $1.26B | $1.13B | $1.06B | $1.06B | $1.02B |
| Net income | $2.28B | $1.83B | $1.59B | $1.57B | $1.72B | $1.33B | $1.19B | $1.12B | $1.02B | $965.8M | $954.3M | $887.4M |
| Net margin | 33.9% | 31.2% | 29.8% | 29.5% | 33.3% | 28.2% | 27.2% | 26.8% | 26.4% | 25.5% | 25.4% | 25.5% |
| Diluted EPS | $1.81 | $1.45 | $1.26 | $1.24 | $1.35 | $1.03 | $0.92 | $0.86 | $0.78 | $0.73 | $0.72 | $0.67 |
| EBITDA | $2.63B | $2.16B | $1.91B | $1.93B | $1.84B | $1.66B | $1.43B | $1.36B | $1.13B | $1.16B | $1.15B | $1.12B |
| Operating cash flow | $1.46B | $1.14B | $1.48B | $1.78B | $2.55B | $1.31B | $741.9M | $1.57B | $862.4M | $1.38B | $1.45B | $951.2M |
| Free cash flow | $1.27B | $809.8M | $1.22B | $1.59B | $2.38B | $1.02B | $553.6M | $1.46B | $761.7M | $1.28B | $1.34B | $874.2M |
| Diluted shares | 1,256.0M | 1,257.3M | 1,261.7M | 1,269.3M | 1,276.9M | 1,288.1M | 1,291.5M | 1,304.1M | 1,310.8M | 1,315.2M | 1,322.2M | 1,331.7M |
Balance sheet
| Period end | Jun 28 | Mar 29 | Dec 28 | Sep 28 | Jun 29 | Mar 30 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $5.58B | $4.75B | $6.18B | $6.69B | $6.39B | $5.45B |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $3.73B | $3.73B | $4.48B | $4.48B | $4.48B | $4.48B |
| Total assets | $23.53B | $20.79B | $21.39B | $21.90B | $21.35B | $19.97B |
| Total liabilities | $11.06B | $10.21B | $11.25B | $11.71B | $11.48B | $10.46B |
| Shareholders' equity | $12.47B | $10.58B | $10.15B | $10.19B | $9.86B | $9.51B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology